{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:02:36Z","timestamp":1790798556111,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtha.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:59:16Z","timestamp":1783407556000},"page":"3531-3537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transfer of emicizumab into breast milk in postpartum acquired hemophilia A"],"prefix":"10.1016","volume":"24","author":[{"given":"Simon Alexander","family":"Krooss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Halling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Varnholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Klingberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbinian","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Werwitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Dobbelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Tiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-0599","authenticated-orcid":false,"given":"Olga","family":"Oleshko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.07.001_bib1","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.07.001_bib2","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1471-0528.2012.03469.x","article-title":"Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry","volume":"119","author":"Tengborn","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.jtha.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2012-07-444877","article-title":"Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients","volume":"121","author":"Whelan","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.001_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2516.2009.02049.x","article-title":"Transplacental transfer of postpartum inhibitors to factor VIII","volume":"16","author":"Lulla","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.07.001_bib5","article-title":"MASAC document 292\u2014National Bleeding Disorder Clinical Practice Recommendations on the off-label use of emicizumab for the treatment of acquired hemophilia A","author":"Lim","year":"2025","journal-title":"National Bleeding Disorders Foundation"},{"key":"10.1016\/j.jtha.2026.07.001_bib6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jtha.2022.10.004","article-title":"A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A","volume":"21","author":"Shima","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.07.001_bib7","doi-asserted-by":"crossref","first-page":"e913","DOI":"10.1016\/S2352-3026(23)00280-6","article-title":"Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study","volume":"10","author":"Tiede","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2026.07.001_bib8","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.humimm.2003.08.025","article-title":"The MHC class I related Fc receptor, FcRn, is expressed in the epithelial cells of the human mammary gland","volume":"64","author":"Cianga","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jtha.2026.07.001_bib9","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1182\/blood-2023-190012","article-title":"Transplacental transfer of emicizumab: experience with emicizumab in a pregnant female with severe hemophilia A: and an inhibitor","volume":"142","author":"Kharel","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.07.001_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0034-1390004","article-title":"Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges","volume":"40","author":"Tiede","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.07.001_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/biom15030325","article-title":"Challenges and opportunities in quantifying bioactive compounds in human breastmilk","volume":"15","author":"Ghith","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtha.2026.07.001_bib12","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/nu13061810","article-title":"The breast milk immunoglobulinome","volume":"13","author":"Rio-Aige","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jtha.2026.07.001_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2026.07.001_bib14","first-page":"315","article-title":"Circulating immune complexes containing anti-VIII antibodies in multi-transfused patients with haemophilia A","volume":"39","author":"Kazatchkine","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jtha.2026.07.001_bib15","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000769","article-title":"Transfer of monoclonal antibodies into breastmilk in neurologic and non-neurologic diseases","volume":"7","author":"LaHue","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtha.2026.07.001_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115354","article-title":"High accumulation of nivolumab in human breast milk: a case report","volume":"166","author":"de Jong","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jtha.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40262-021-00985-4","article-title":"Vedolizumab concentrations in breast milk: results from a prospective, postmarketing, milk-only lactation study in nursing mothers with inflammatory bowel disease","volume":"60","author":"Sun","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtha.2026.07.001_bib18","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/acn3.51893","article-title":"Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions","volume":"10","author":"Anderson","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jtha.2026.07.001_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001167","article-title":"Concentrations of subcutaneously administered belimumab in human breast milk of a woman with systemic lupus erythematosus: a case report","volume":"11","author":"Blomjous","year":"2024","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jtha.2026.07.001_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715195","article-title":"Drug and neurofilament levels in serum and breastmilk of women with multiple sclerosis exposed to natalizumab during pregnancy and lactation","volume":"12","author":"Proschmann","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.07.001_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/17562864221150040","article-title":"Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis","volume":"16","author":"Callegari","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jtha.2026.07.001_bib22","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/annrheumdis-2017-211384","article-title":"Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study","volume":"76","author":"Clowse","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jtha.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp-2022-329545","article-title":"Safety of breast feeding during rituximab treatment in multiple sclerosis","volume":"94","author":"R\u00f8d","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jtha.2026.07.001_bib24","article-title":"Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions","volume":"71","author":"Krysko","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jtha.2026.07.001_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0890334414566237","article-title":"Transfer of natalizumab into breast milk in a mother with multiple sclerosis","volume":"31","author":"Baker","year":"2015","journal-title":"J Hum Lact"},{"key":"10.1016\/j.jtha.2026.07.001_bib26","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.cell.2021.02.031","article-title":"The multifaceted roles of breast milk antibodies","volume":"184","author":"Atyeo","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2026.07.001_bib27","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3389\/fmicb.2018.02755","article-title":"Microbial biomarkers of intestinal barrier maturation in preterm infants","volume":"9","author":"Ma","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jtha.2026.07.001_bib28","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fimmu.2020.01153","article-title":"The immature gut barrier and its importance in establishing immunity in newborn mammals","volume":"11","author":"Westr\u00f6m","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2026.07.001_bib29","article-title":"Pharmacodynamic interaction between emicizumab and coagulation factor VIII","author":"Chill","year":"2026","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626004216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:46:24Z","timestamp":1790797584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626004216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1538783626004216"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.001","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfer of emicizumab into breast milk in postpartum acquired hemophilia A","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}